Cardlytics Inc reports results for the quarter ended June 30 - Earnings Summary

• Cardlytics Inc CDLX.OQ reported a quarterly adjusted loss of 13 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of -15 cents. The mean expectation of five analysts for the quarter was for a loss of 16 cents per share. Wall Street expected results to range from -22 cents to -8 cents per share.

• Revenue fell 9.2% to $63.25 million from a year ago; analysts expected $64.02 million.

• Cardlytics Inc's reported EPS for the quarter was a loss of 18 cents​.

• The company reported a quarterly loss of $9.28 million.

• Cardlytics Inc shares had risen by 11.9% this quarter and lost 50.4% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 4.4% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy," 5 "hold" and 1 "sell" or "strong sell."

• Wall Street's median 12-month price target for Cardlytics Inc is $2.50, about 29.6% above its last closing price of $1.76

This summary was machine generated from LSEG data August 6 at 10:30 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)